AU2065501A - Human semaphorin zsmf-16 - Google Patents

Human semaphorin zsmf-16

Info

Publication number
AU2065501A
AU2065501A AU20655/01A AU2065501A AU2065501A AU 2065501 A AU2065501 A AU 2065501A AU 20655/01 A AU20655/01 A AU 20655/01A AU 2065501 A AU2065501 A AU 2065501A AU 2065501 A AU2065501 A AU 2065501A
Authority
AU
Australia
Prior art keywords
zsmf
human semaphorin
semaphorin
human
semaphorin zsmf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20655/01A
Inventor
Kevin P. Foley
James L. Holloway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of AU2065501A publication Critical patent/AU2065501A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU20655/01A 1999-12-06 2000-12-06 Human semaphorin zsmf-16 Abandoned AU2065501A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45556099A 1999-12-06 1999-12-06
US09455560 1999-12-06
PCT/US2000/033116 WO2001040278A2 (en) 1999-12-06 2000-12-06 Human semaphorin zsmf-16

Publications (1)

Publication Number Publication Date
AU2065501A true AU2065501A (en) 2001-06-12

Family

ID=23809325

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20655/01A Abandoned AU2065501A (en) 1999-12-06 2000-12-06 Human semaphorin zsmf-16

Country Status (2)

Country Link
AU (1) AU2065501A (en)
WO (1) WO2001040278A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110494151A (en) * 2017-02-14 2019-11-22 耶路撒冷希伯来大学伊森姆研究发展有限公司 NAF-1 derived peptide and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5416197A (en) * 1993-10-15 1995-05-16 Trustees Of The University Of Pennsylvania Antibodies which bind human collapsin
US5654173A (en) * 1996-08-23 1997-08-05 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
DE69738302T2 (en) * 1996-09-11 2008-09-04 Dainippon Sumitomo Pharma Co., Ltd. NEW SEMAPHORIN GENE: SEMAPHORIN Y
AU2000299A (en) * 1997-12-19 1999-07-12 Zymogenetics Inc. Semaphorin zsmf-3
WO1999045114A2 (en) * 1998-03-03 1999-09-10 Zymogenetics, Inc. Human semaphorin zsmf-7
WO1999047671A2 (en) * 1998-03-13 1999-09-23 Lukanidin Eugene M Dna sequences encoding semaphorin-h and diagnosis of metastatic cancer

Also Published As

Publication number Publication date
WO2001040278A3 (en) 2001-11-29
WO2001040278A2 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
AU4198500A (en) Suture-passing forceps
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU4431000A (en) Novel use
AU6599800A (en) Endoscope
AU1608201A (en) Human zven proteins
AU5967600A (en) Candystraw
AU7514700A (en) Cyanopiperidines
AU4115400A (en) Short-circuiter
AU6335000A (en) Depthimeter
AU2982799A (en) Human semaphorin zsmf-7
AU6440900A (en) Homogentisate-dioxygenase
AU2804600A (en) Arylaminoalkylamides
AU2023701A (en) Sketcher
AU2699800A (en) Organoceramics
AU6098300A (en) Follistatin-3
AU4916900A (en) Benzofuranylsulfonates
AU4561600A (en) Benzofuranylaminoalcohols
AU4456800A (en) Human hac3
AU2227999A (en) Human ependymin
AU1901801A (en) Glucofuranoses
AU2582200A (en) Windturbine
AU7303400A (en) Osseo-distractor
AU7513400A (en) Hydantoin-racemase
AU1915601A (en) Periotome

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase